StemCell Institute Inc.
7096株式会社ステムセル研究所
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-14For the first half of the fiscal year to 2026-03: Revenue ¥1.4 billion, Ordinary income ¥0.1 billion, Net income ¥0.1 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥1.4bn | — |
| Ordinary profit | ¥137m | — |
| Net profit to owners | ¥85m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/7096/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-31- Revenue
- ¥2.8bn
- Net income
- ¥156m
- ROE
- 5.8%
- Equity ratio
- 33.0%
- Dividend / share
- —
- Employees
- 136
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥2,811m | ¥156m | ¥8,125m | ¥3,074m | 5.8% | ¥15.44 | ¥74m |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 5.81 | 30.8 |
| Ordinary margin | 0.0773 | 55.3 |
| Equity ratio, % | 33.01 | 17.2 |
| Revenue growth | — | — |
| Net income growth | — | — |
| Operating cash flow / assets | 0.009 | 19.2 |
Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥440m of reported debt repriced by 50 basis points, a year's interest would rise by ¥2m, 3.0% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/7096/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states them/v1/companies/7096/buybacksSegments, votes and tender offers
Stated in EDINET filings/v1/companies/7096/votingOwnership changes
All companies →- 2025-03-03
NIHON TRIM CO.,LTD. reduced holdings in StemCell Institute Inc. (7096) to 70.02% from 72.06%.
- 2025-02-04
NIHON TRIM CO.,LTD. disclosed a 72.06% stake in StemCell Institute Inc. (7096), crossing the 5% reporting threshold.
- 2025-02-04
Holdings of NIHON TRIM CO.,LTD. in StemCell Institute Inc. (7096) moved above 10% (new -> 72.06%).
- 2025-02-04
Holdings of NIHON TRIM CO.,LTD. in StemCell Institute Inc. (7096) moved above 20% (new -> 72.06%).
- 2025-02-04
Holdings of NIHON TRIM CO.,LTD. in StemCell Institute Inc. (7096) moved above 33.4% (new -> 72.06%).
- 2025-02-04
Holdings of NIHON TRIM CO.,LTD. in StemCell Institute Inc. (7096) moved above 50% (new -> 72.06%).
- 2025-02-04
Trim Medical Holdings Inc. cut holdings in StemCell Institute Inc. (7096) to 0.00% from 72.57%, below the 5% threshold.
- 2025-02-04
Holdings of Trim Medical Holdings Inc. in StemCell Institute Inc. (7096) moved below 10% (72.57% -> 0.00%).
- 2025-02-04
Holdings of Trim Medical Holdings Inc. in StemCell Institute Inc. (7096) moved below 20% (72.57% -> 0.00%).
- 2025-02-04
Holdings of Trim Medical Holdings Inc. in StemCell Institute Inc. (7096) moved below 33.4% (72.57% -> 0.00%).
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| 株式会社日本トリム | 2025-02-01 – 2025-02-26 | -210,000 | −2.05pt | ¥1,150 | ¥1,150–1,150 |
| 株式会社トリムメディカルホールディングス | 2025-02-01 – 2025-02-01 | 0 | 0.00pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/7096/trades.
5% filings
Large shareholding reports on 7096| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2025-03-03 | NIHON TRIM.,CO.LTD. | 70.02% | −2.04pt | — |
| 2025-02-04 | NIHON TRIM.,CO.LTD. | 72.06% | — | — |
| 2025-02-04 | Trim Medical Holdings Inc. | 0.00% | −72.57pt | — |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 1 issues
- Book value
- ¥24m
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 0
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| baby calendar Inc. 7363 | ¥24m | 0.0% | no |
Purposes, all holdings and mutual flags via /v1/companies/7096/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| 株式会社日本トリム | 7,174,200 | 71.24% |
| 名古屋中小企業投資育成株式会社 | 168,000 | 1.67% |
| individual holder | 90,200 | 0.90% |
| Supercell Biotechnology Corporation | 70,000 | 0.70% |
| ステムセル研究所従業員持株会 | 65,989 | 0.66% |
| individual holder | 51,800 | 0.51% |
| individual holder | 51,400 | 0.51% |
| 楽天証券株式会社 | 46,200 | 0.46% |
| individual holder | 42,900 | 0.43% |
| individual holder | 32,400 | 0.32% |
Get this as JSON
GET /v1/companies/7096
GET /v1/companies/7096/financials
GET /v1/companies/7096/details
GET /v1/companies/7096/segments
GET /v1/companies/7096/voting
GET /v1/companies/7096/tender-offers
GET /v1/companies/7096/indicators
GET /v1/companies/7096/earnings-releases
GET /v1/events?ticker=7096
GET /v1/companies/7096/trades
GET /v1/companies/7096/cross-holdings
GET /v1/companies/7096/brief